ReviewCancers2026

Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design.

Xin Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.